Solution Suites

Diagnostic Solutions

Treatment Solutions

Solution Suites

We are designing comprehensive solution suites for cardiology and neurology to deliver clinical value throughout the entire patient care process. We have strategically selected clinical scenarios in which we believe AI-powered solutions can improve patient care, physician satisfaction, and clinical efficiency.

Descriptions of product candidates contain forward-looking statements intended for investors. 

Cardiovascular Solutions

The deep learning-based solutions in our Cardiovascular Suite will address the unmet clinical needs of patients with cardiovascular disease. The product candidates in our Cardiovascular Suite will be used in early screening, diagnosis, treatment, and post-treatment maintenance.

Screening

AI-aided CTA Analysis

DeepVessel Cardisight

Diagnosis

CT-FFR
DeepVessel FFR

DeepVessel FFR

Core Product
DeepVessel Angio FFR

DeepVessel AngioFFR

DeepVessel Cardisight

Treatment

PCI Planning & Navigation
DeepVessel SmartPCI

DeepVessel SmartPCI

PCI Robotics
DeepVessel AngioBot

DeepVessel AngioBot

Ultrasound ShockPulse
DeepVessel ShockPulse

DeepVessel ShockPulse

Follow-Up

AI-aided CTA Analysis

DeepVessel Cardisight

Screening

AI-aided CTA Analysis

DeepVessel Cardisight

Diagnosis

CT-FFR – Core Product
DeepVessel FFR

DeepVessel FFR

DeepVessel Angio FFR

DeepVessel AngioFFR

Treatment

PCI Planning & Navigation
DeepVessel SmartPCI

DeepVessel SmartPCI

PCI Robotics
DeepVessel AngioBot

DeepVessel AngioBot

Ultrasound ShockPulse
DeepVessel ShockPulse

DeepVessel ShockPulse

Follow-Up

AI-aided CTA Analysis

DeepVessel Cardisight

Core Product

DeepVessel FFR

DeepVessel Certification 2020
DeepVessel FFR* uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary CT angiogram scans. The software reduces unnecessary invasive testing to lower costs and complications.

*CE-marked, NMPA approved. Not for sale in the United States

Product Candidates

DeepVessel Stroke

We are continuing to develop a comprehensive Stroke Suite that will build on the current functionality of CuraRad-ICH, Keya Medical’s first FDA-cleared product for intracranial hemorrhage (ICH) detection. We are seeking to expand the indications of DeepVessel Stroke by adding additional modules to the software.

ICH
Triage
DeepVessel Stroke

CuraRad ICH

FDA Cleared
Intracranial Hemorrhage
DeepVessel Stroke

DeepVessel ICH

ASPECT
Scoring​
DeepVessel Stroke

DeepVessel ASPECTS

Large Vessel Occlusion
DeepVessel Stroke

DeepVessel LVO

CT Perfusion
Analysis​
DeepVessel Stroke

DeepVessel CTP

ICH Triage
DeepVessel Stroke

CuraRad ICH

FDA Cleared

Intracranial Hemorrhage
DeepVessel Stroke

DeepVessel ICH

ASPECT Scoring​
DeepVessel ASPECTS

DeepVessel ASPECTS

Large Vessel Occlusion
DeepVessel Cerebright  and LVO

DeepVessel LVO

CT Perfusion Analysis​
DeepVessel CTP

DeepVessel CTP

CuraRad-ICH

DeepVessel Certification 2020

CuraRad-ICH is a software workflow prioritization tool designed to reduce radiologist turnaround time for suspected ICH cases in non-contrast head CT scans.

*510(k) cleared by the U.S. Food & Drug Administration

Product Candidates